Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate for Acute Manic or Mixed Episodes in Bipolar I Disorder
NCT00240721Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 2000
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of topiramate in bipolar I disorder (3 arms), sponsored by Johnson & Johnson. Primary endpoint: Young Mania Rating Scale at 21 days. Started Oct 2000; status: completed.
02
Drugs
topiramate
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00240721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240721.